Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 619

1.

Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer.

Tomizawa K, Shimizu S, Ohara S, Fujino T, Nishino M, Sesumi Y, Kobayashi Y, Sato K, Chiba M, Shimoji M, Suda K, Takemoto T, Mitsudomi T.

Lung Cancer. 2017 Oct;112:57-61. doi: 10.1016/j.lungcan.2017.08.004. Epub 2017 Aug 4.

PMID:
29191601
2.

[Analysis of Patients Who Received Enteral Nutrition in the Course of Chemotherapy].

Kawada J, Nishino M, Hata T, Ogino T, Hoshino H, Okano M, Nagai K, Kim Y, Okuyama M, Tsujinaka T.

Gan To Kagaku Ryoho. 2017 Oct;44(10):900-902. Japanese.

PMID:
29066689
3.

Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, Washko GR, Rosas IO, Hatabu H, Sholl LM, Hunninghake GM.

Am J Respir Crit Care Med. 2017 Sep 21. doi: 10.1164/rccm.201708-1679LE. [Epub ahead of print] No abstract available.

PMID:
28934558
4.

Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors.

Hamamoto J, Yasuda H, Aizawa K, Nishino M, Nukaga S, Hirano T, Kawada I, Naoki K, Betsuyaku T, Soejima K.

Oncol Lett. 2017 Sep;14(3):3559-3565. doi: 10.3892/ol.2017.6591. Epub 2017 Jul 18.

5.

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Nishino M, Hatabu H, Sholl LM, Ramaiya NH.

Radiographics. 2017 Sep-Oct;37(5):1371-1387. doi: 10.1148/rg.2017170015.

PMID:
28898185
6.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700537. doi: 10.1183/13993003.00537-2017. Print 2017 Sep.

7.

Electrospun tri-layered zein/PVP-GO/zein nanofiber mats for providing biphasic drug release profiles.

Lee H, Xu G, Kharaghani D, Nishino M, Song KH, Lee JS, Kim IS.

Int J Pharm. 2017 Oct 5;531(1):101-107. doi: 10.1016/j.ijpharm.2017.08.081. Epub 2017 Aug 19.

PMID:
28830784
8.

Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma.

Nishino M, Ozaki M, Hegab AE, Hamamoto J, Kagawa S, Arai D, Yasuda H, Naoki K, Soejima K, Saya H, Betsuyaku T.

J Cancer. 2017 Jul 1;8(10):1774-1785. doi: 10.7150/jca.19732. eCollection 2017.

9.

Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report.

Mehrzad R, Nishino M, Nucera C, Dias-Santagata D, Hennessey JV, Hasselgren PO.

Int J Surg Case Rep. 2017;38:180-184. doi: 10.1016/j.ijscr.2017.06.067. Epub 2017 Jul 20.

10.

Arthroconidia in Lung Tissue: An Unusual Histopathological Finding in Pulmonary Coccidioidomycosis.

Brennan-Krohn T, Yoon E, Nishino M, Kirby JE, Riedel S.

Hum Pathol. 2017 Aug 1. pii: S0046-8177(17)30265-4. doi: 10.1016/j.humpath.2017.07.013. [Epub ahead of print]

PMID:
28778515
11.

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

Engstrom LD, Aranda R, Lee M, Tovar EA, Essenburg CJ, Madaj Z, Chiang H, Briere D, Hallin J, Lopez-Casas PP, Baños N, Menendez C, Hidalgo M, Tassell V, Chao R, Chudova DI, Lanman RB, Olson P, Bazhenova L, Patel SP, Graveel C, Nishino M, Shapiro GI, Peled N, Awad MM, Jänne PA, Christensen JG.

Clin Cancer Res. 2017 Nov 1;23(21):6661-6672. doi: 10.1158/1078-0432.CCR-17-1192. Epub 2017 Aug 1.

PMID:
28765324
12.

Outcomes for Atrial Fibrillation Patients with Silent Left Atrial Thrombi Detected by Transesophageal Echocardiography.

Inoue K, Suna S, Iwakura K, Oka T, Masuda M, Furukawa Y, Egami Y, Kashiwase K, Hirata A, Watanabe T, Takeda T, Mizuno H, Minamiguchi H, Kitamura T, Dohi T, Nakatani D, Hikoso S, Okuyama Y, Sakata Y; OCVC Investigators.

Am J Cardiol. 2017 Sep 15;120(6):940-946. doi: 10.1016/j.amjcard.2017.06.022. Epub 2017 Jun 29.

PMID:
28750827
13.

Determination of cell fate in skeletal muscle following BMP gene transfer by in vivo electroporation.

Kawai M, Ohmori YK, Nishino M, Yoshida M, Tabata K, Hirota DS, Ryu-Mon A, Yamamoto H, Sonobe J, Kataoka YH, Shiotsu N, Ikegame M, Maruyama H, Yamamoto T, Bessho K, Ohura K.

Eur J Histochem. 2017 May 5;61(2):2772. doi: 10.4081/ejh.2017.2772.

14.

PFC Blood Oxygenation Changes in Four Different Cognitive Tasks.

Takeda T, Kawakami Y, Konno M, Matsuda Y, Nishino M, Suzuki Y, Kawano Y, Nakajima K, Ozawa T, Kondo Y, Sakatani K.

Adv Exp Med Biol. 2017;977:199-204. doi: 10.1007/978-3-319-55231-6_27.

PMID:
28685446
15.

Tumor Response Dynamics of Advanced Non-small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome.

Nishino M, Dahlberg SE, Adeni AE, Lydon CA, Hatabu H, Jänne PA, Hodi FS, Awad MM.

Clin Cancer Res. 2017 Oct 1;23(19):5737-5744. doi: 10.1158/1078-0432.CCR-17-1434. Epub 2017 Jul 5.

PMID:
28679767
16.

Well-leg compartment syndrome after laparoscopic low anterior resection for lower rectal cancer in the lithotomy position: A case report.

Nishino M, Okano M, Kawada J, Kim Y, Yamada M, Tsujinaka T.

Asian J Endosc Surg. 2017 Jul 5. doi: 10.1111/ases.12410. [Epub ahead of print]

PMID:
28677871
17.

Monitoring immune-checkpoint blockade: response evaluation and biomarker development.

Nishino M, Ramaiya NH, Hatabu H, Hodi FS.

Nat Rev Clin Oncol. 2017 Nov;14(11):655-668. doi: 10.1038/nrclinonc.2017.88. Epub 2017 Jun 27. Review.

PMID:
28653677
18.

Difference in the craniocaudal gradient of the maximum pixel value change rate between chronic obstructive pulmonary disease patients and normal subjects using sub-mGy dynamic chest radiography with a flat panel detector system.

Yamada Y, Ueyama M, Abe T, Araki T, Abe T, Nishino M, Jinzaki M, Hatabu H, Kudoh S.

Eur J Radiol. 2017 Jul;92:37-44. doi: 10.1016/j.ejrad.2017.04.016. Epub 2017 Apr 27.

19.

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions.

Nishino M, Giobbie-Hurder A, Manos MP, Bailey N, Buchbinder EI, Ott PA, Ramaiya NH, Hodi FS.

Clin Cancer Res. 2017 Aug 15;23(16):4671-4679. doi: 10.1158/1078-0432.CCR-17-0114. Epub 2017 Jun 7.

PMID:
28592629
20.

Osimertinib in EGFR T790M-Positive Lung Cancer.

Nishino M, Hatabu H.

N Engl J Med. 2017 May 18;376(20):1992-3. doi: 10.1056/NEJMc1703339. No abstract available.

PMID:
28517914

Supplemental Content

Loading ...
Support Center